Segment Disclosures - Schedule of Information for the Reportable Segments (Details) - USD ($) $ in Thousands	3 Months Ended					9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	$ 700,397			$ 556,243		$ 2,002,461	$ 1,627,351
Plus: Adjustments to NOI	27,825			13,389		80,842	37,670
Interest income and other	14,301			5,360		27,884	16,802
Interest expense	(74,105)			(50,510)		(209,922)	(147,547)
Depreciation and amortization	(280,019)			(184,559)		(782,736)	(561,357)
General and administrative	(23,216)			(23,093)		(73,233)	(73,576)
Transaction and merger-related costs	(7,134)			(36)		(122,113)	(3,098)
Impairments and loan loss reserves, net	(441)			550		(11,346)	156
Gain (loss) on sales of real estate, net	62,325			0		187,624	86,463
Other income (expense), net	982			1,481		83,502	4,208
Less: Government grant income							(184)
Less: Healthpeak’s share of unconsolidated joint venture NOI	(7,664)			(1,912)		(20,068)	(4,882)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI	6,883			6,382		20,207	19,228
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures	98,510			67,342		276,402	254,941
Outpatient Medical
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Gain (loss) on sales of real estate, net	60,000	$ 67,000	$ 3,000		$ 21,000
Lab
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Gain (loss) on sales of real estate, net		$ 55,000			$ 60,000
Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	686,096			550,883		1,974,577	1,610,549
Government grant income							184
Healthpeak’s share of unconsolidated joint venture total revenues	12,307			3,171		31,111	8,764
Noncontrolling interests’ share of consolidated joint venture total revenues	(9,734)			(8,889)		(28,148)	(26,813)
Operating expenses	(280,279)			(232,734)		(797,835)	(677,659)
Healthpeak’s share of unconsolidated joint venture operating expenses	(4,643)			(1,259)		(11,043)	(3,882)
Noncontrolling interests’ share of consolidated joint venture operating expenses	2,851			2,507		7,941	7,585
Adjustments to NOI	(27,825)			(13,389)		(80,842)	(37,670)
Adjusted NOI for reportable segments	378,773			300,290		1,095,761	881,058
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures	98,510			67,342		276,402	254,941
Operating Segment | Outpatient Medical
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	317,659			191,016		888,446	564,644
Government grant income							0
Healthpeak’s share of unconsolidated joint venture total revenues	7,065			746		16,707	2,245
Noncontrolling interests’ share of consolidated joint venture total revenues	(9,734)			(8,735)		(27,952)	(26,364)
Operating expenses	(106,484)			(67,693)		(299,455)	(197,442)
Healthpeak’s share of unconsolidated joint venture operating expenses	(2,832)			(301)		(6,380)	(895)
Noncontrolling interests’ share of consolidated joint venture operating expenses	2,851			2,474		7,889	7,477
Adjustments to NOI	(11,020)			(3,547)		(27,573)	(11,373)
Adjusted NOI for reportable segments	197,505			113,960		551,682	338,292
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures
Operating Segment | Lab
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	225,592			226,059		663,619	654,829
Government grant income							0
Healthpeak’s share of unconsolidated joint venture total revenues	5,242			2,425		14,404	6,519
Noncontrolling interests’ share of consolidated joint venture total revenues	0			(154)		(196)	(449)
Operating expenses	(64,075)			(60,268)		(177,571)	(172,666)
Healthpeak’s share of unconsolidated joint venture operating expenses	(1,811)			(958)		(4,663)	(2,987)
Noncontrolling interests’ share of consolidated joint venture operating expenses	0			33		52	108
Adjustments to NOI	(16,900)			(9,842)		(51,624)	(25,618)
Adjusted NOI for reportable segments	148,048			157,295		444,021	459,736
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures
Operating Segment | CCRC
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	142,845			133,808		422,512	391,076
Government grant income							184
Healthpeak’s share of unconsolidated joint venture total revenues	0			0		0	0
Noncontrolling interests’ share of consolidated joint venture total revenues	0			0		0	0
Operating expenses	(109,720)			(104,773)		(320,809)	(307,551)
Healthpeak’s share of unconsolidated joint venture operating expenses	0			0		0	0
Noncontrolling interests’ share of consolidated joint venture operating expenses	0			0		0	0
Adjustments to NOI	95			0		(1,645)	(679)
Adjusted NOI for reportable segments	33,220			29,035		100,058	83,030
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures